Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Malignant Lymphoma

  Free Subscription


07.07.2025

2 Am J Clin Pathol
1 Am J Hematol
1 Am J Surg Pathol
1 BMC Cancer
1 BMC Neurol
1 Bone Marrow Transplant
4 Br J Haematol
1 Eur J Haematol
3 Haematologica
1 Int J Radiat Oncol Biol Phys
1 J Natl Cancer Inst
3 Leuk Lymphoma
1 Leukemia
1 Oncol Rep
1 Oncology (Williston Park)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. BHATTARAI N, Cook JR
    IRTA1 expression in extranodal marginal zone (MALT) lymphoma is variable across anatomic sites.
    Am J Clin Pathol. 2025 Jun 30:aqaf056. doi: 10.1093.
    PubMed         Abstract available

  2. GISRIEL SD, Yuan J, Tang H, Xu J, et al
    Concurrent or subsequent lymphomatous effusion in large B-cell lymphoma portends a dismal prognosis: A multi-institutional study.
    Am J Clin Pathol. 2025 Jun 29:aqaf057. doi: 10.1093.
    PubMed         Abstract available


    Am J Hematol

  3. LOSSOS IS, Jiang X, Patel K, Moalem KN, et al
    Association Between Moraxella catarrhalis and Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    Am J Hematol. 2025 Jul 4. doi: 10.1002/ajh.27762.
    PubMed         Abstract available


    Am J Surg Pathol

  4. DE CASTRO JVA, Kim J, Tyagi M, Xi L, et al
    Genomics of T-Cell Lymphomas With CD30/CD15 Co-Expression: Comparison With Anaplastic Large-Cell Lymphoma, ALK-Negative.
    Am J Surg Pathol. 2025 Jul 3. doi: 10.1097/PAS.0000000000002447.
    PubMed         Abstract available


    BMC Cancer

  5. WANG X, Li Z, Chang Y, Li S, et al
    Early assessment of therapeutic efficacy in lymphoma patients via a blood-based multi-omics response monitoring test.
    BMC Cancer. 2025;25:1078.
    PubMed         Abstract available


    BMC Neurol

  6. ZHANG Z, Ling C, Zhang Y, Sun W, et al
    Clinically probable paraneoplastic vasculitic peripheral neuropathy in primary central nervous system lymphoma: a case report.
    BMC Neurol. 2025;25:252.
    PubMed         Abstract available


    Bone Marrow Transplant

  7. BEKADJA MA, Niederwieser D, Kharfan-Dabaja MA, El Fakih R, et al
    Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2025 Jun 30. doi: 10.1038/s41409-025-02664.
    PubMed        


    Br J Haematol

  8. ALZAHRANI M, Gerrie AS, Sehn LH, Scott DW, et al
    Therapeutic advances and gradual improvement in overall survival in mantle cell lymphoma over four decades.
    Br J Haematol. 2025 Jul 2. doi: 10.1111/bjh.20239.
    PubMed        

  9. GASCON P, Frankel D, Fritz S, Comet A, et al
    Vitrectomy as a rapid diagnostic tool for lymphoma: Cytology and flow cytometry approach.
    Br J Haematol. 2025 Jul 1. doi: 10.1111/bjh.20250.
    PubMed        

  10. CASSANELLO G, Luttwak E, Brown S, Devlin SM, et al
    Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience.
    Br J Haematol. 2025 Jul 1. doi: 10.1111/bjh.20234.
    PubMed         Abstract available

  11. SHARP J, Zhao Q, Voorhees TJ, Bond DA, et al
    Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma.
    Br J Haematol. 2025 Jun 30. doi: 10.1111/bjh.20240.
    PubMed         Abstract available


    Eur J Haematol

  12. ZHU M, Li T, Han S, Zhao D, et al
    Construction of Lymphoma Organoids and Applications in Tumor Microenvironment Research.
    Eur J Haematol. 2025 Jun 30. doi: 10.1111/ejh.14448.
    PubMed         Abstract available


    Haematologica

  13. SHOUSE G, Chen C, Muir A, Popplewell L, et al
    Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial.
    Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2024.286945.
    PubMed         Abstract available

  14. DANILOV AV, Li H, Shadman M, Rimsza L, et al
    Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial.
    Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2025.288057.
    PubMed         Abstract available

  15. DOGLIOTTI I, Federico M
    BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?
    Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2025.288196.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  16. HOPPE BS, Mailhot-Vega RB, Renfro LA, Pei Q, et al
    Comparison of Contemporary Radiotherapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331.
    Int J Radiat Oncol Biol Phys. 2025 Jun 28:S0360-3016(25)04518.
    PubMed         Abstract available


    J Natl Cancer Inst

  17. GANGARAJU R, Chen Y, Hageman L, Bosworth A, et al
    Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma.
    J Natl Cancer Inst. 2025 Jul 2:djaf164. doi: 10.1093.
    PubMed         Abstract available


    Leuk Lymphoma

  18. DERENZINI E, Gibb A, Kwiatek M, Strati P, et al
    Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug profile and expert opinion on the prevention and management of adverse events.
    Leuk Lymphoma. 2025 Jun 30:1-13. doi: 10.1080/10428194.2025.2520440.
    PubMed         Abstract available

  19. MAURER K, Jacobson CA
    T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategies.
    Leuk Lymphoma. 2025;66:1189-1197.
    PubMed         Abstract available

  20. LUTTWAK E, Robin ET, Drill E, Boardman A, et al
    Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.
    Leuk Lymphoma. 2025;66:1276-1283.
    PubMed         Abstract available


    Leukemia

  21. MIELAND AO, Petrosino G, Dejung M, Chen JX, et al
    The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells.
    Leukemia. 2025;39:1756-1768.
    PubMed         Abstract available


    Oncol Rep

  22. LIU Q, Ling J, Li Z, Bi L, et al
    Advances in lymphoma biomarkers research based on proteomics technology (Review).
    Oncol Rep. 2025;54:108.
    PubMed         Abstract available


    Oncology (Williston Park)

  23. HAO-YU D, Yi-Wei C, Shao-Ke L, Dong-Liang L, et al
    Extranodal NK/T-Cell Lymphoma Misdiagnosed as Pulmonary Infection.
    Oncology (Williston Park). 2025;null:198-203.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.